Episode Details
Back to Episodes
Can a GLP-1 Pill Revive Novo Nordisk?
Published 2 months, 1 week ago
Description
Ed Elson speaks with Alex Heath, host of the ACCESS Podcast, about why Nvidia is dominating the news out of the CES conference. Then Jared Holz, Healthcare Equity Strategist at Mizuho, joins the show to discuss what Novo Nordisk’s new Wegovy pill means for the healthcare industry.
Check out our latest Prof G Markets newsletter
Follow Prof G Markets on Instagram
Follow Ed on Instagram, X and Substack
Follow Scott on Instagram
Learn more about your ad choices. Visit podcastchoices.com/adchoices